A biomanufacturing facility that Pfizer abandoned two years into a $500 million build-out has changed hands for a fraction of that investment, landing with a life science real estate specialist willing to bet on finishing what one of the world's largest drugmakers walked away from. An entity affiliated with Breakthrough Properties has acquired the former […]
Thank you for your interest in The Registry. If you'd like to read further, you must Subscribe or Log In below to read the rest of this content.

Signup for news and special announcements!
You have successfully joined our subscriber list.
Seattle voters are on track to double the city's dedicated transit sales...
ByThe RegistryNovember 4, 2026A Seattle multifamily investor has paid about $246,000 per unit for a...
ByThe RegistryNovember 4, 2026SITE Centers has agreed to sell its retail condominium portfolio in Portland’s...
ByThe RegistryNovember 4, 2026Madison Realty Capital and Red Cove Capital have stacked $131.9 million of...
ByThe RegistryNovember 4, 2026